TNF and ovarian cancer: Reports show that the CK2α knockdown or inhibition of CK2 (CX-4945) can significantly reduce the release of TNF, IL-6 and VEGF cytokines in ovarian cancer cells by suppressing the JAK/STAT3 and NOTCH signal pathway (73).